Advisory Research »

Monte Rosa Therapeutics shares owned by Advisory Research

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Advisory Research from 13F filings

Historical chart of Advisory Research investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Advisory Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Advisory Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $991k 63k 15.68

More positions owned by Advisory Research

Trimas Corp Com New (TRS)
KAR Auction Services (OPLN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Daily Journal Corporation (DJCO)
Tapestry (TPR)
Philip Morris International (PM)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Myers Industries (MYE)
Viad (PRSU)
Bel Fuse CL B (BELFB)
MGIC Investment (MTG)
Microsoft Corporation (MSFT)
John Bean Technologies Corporation (JBTM)
Cme (CME)

View all positions for Advisory Research

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics